论文信息 - Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study - 字舞流文

Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study

G. Feldman | F. Patalano | P. D’Andrea | C. Laforce | S. Spangenthal | Joerg H. Eckert | M. Henley